NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Ruxolitinib for treating polycythaemia vera (terminated appraisal) - NICE TAG 356

Ruxolitinib for treating polycythaemia vera (terminated appraisal) - NICE TAG 356

NICE is unable to make a recommendation about the use in the NHS of ruxolitinib for treating polycythaemia vera that is resistant to hydroxycarbamide or for people who cannot tolerate hydroxycarbamide because no evidence submission was received from Novartis Pharmaceuticals for the technology.

http://www.nice.org.uk/guidance/ta356

Site by Devopa
© Copyright 2019 NHS. All rights reserved.